Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
Hidradenitis Suppurativa Archives - Page 20 of 32 - The Dermatology Digest
Subscribe
Search

Category: Hidradenitis Suppurativa

HS Pipeline Watch: MoonLake Immunotherapeutics’ Sonelokimab Advances to Phase 3

The first patients have been screened at a U.S. trial site in MoonLake Immunotherapeutics’ global Phase 3 clinical program, VELA, evaluating sonelokimab in hidradenitis suppurativa (HS). Sonelokimab is a Nanobody designed to directly target sites of inflammation by inhibiting the IL-17A/A, IL-17A/F, and IL-17F/F dimers and to penetrate difficult-to-reach inflamed tissues. The initiation of this […]